Identification of A Novel SBF2 Frameshift Mutation in Charcot–Marie–Tooth Disease Type 4B2 Using Whole-exome Sequencing

Charcot–Marie–Tooth disease type 4B2 with early-onset glaucoma (CMT4B2, OMIM 604563) is a genetically-heterogeneous childhood-onset neuromuscular disorder. Here, we report the case of a 15-year-old male adolescent with lower extremity weakness, gait abnormalities, foot deformities and early-onset glaucoma. Since clinical diagnosis alone was insufficient for providing pathogenetic evidence to indicate that the condition belonged to a consanguineous family, we applied whole-exome sequencing to samples from the patient, his parents and his younger brother, assuming that the patient’s condition is transmitted in an autosomal recessive pattern. A frame-shift mutation, c.4571delG (P.Gly1524Glufs∗42), was revealed in the CMT4B2-related gene SBF2 (also known as MTMR13, MIM 607697), and this mutation was found to be homozygous in the proband and heterozygous in his parents and younger brother. Together with the results of clinical diagnosis, this case was diagnosed as CMT4B2. Our finding further demonstrates the use of whole-exome sequencing in the diagnosis and treatment of rare diseases.

[1]  Aldo Quattrone,et al.  Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2 , 2000, Nature Genetics.

[2]  Salwa Hindawi,et al.  Identification of a novel SBF2 missense mutation associated with a rare case of thrombocytopenia using whole-exome sequencing , 2013, Journal of Thrombosis and Thrombolysis.

[3]  M. Pericak-Vance,et al.  Identification of a new locus for autosomal recessive Charcot-Marie-Tooth disease with focally folded myelin on chromosome 11p15. , 1999, Genomics.

[4]  Giuseppe Remuzzi,et al.  Monogenic diseases that can be cured by liver transplantation. , 2013, Journal of hepatology.

[5]  M Nakagawa,et al.  SET binding factor 2 (SBF2) mutation causes CMT4B with juvenile onset glaucoma , 2004, Neurology.

[6]  Soo-A Kim,et al.  Myotubularin and MTMR2, Phosphatidylinositol 3-Phosphatases Mutated in Myotubular Myopathy and Type 4B Charcot-Marie-Tooth Disease* , 2002, The Journal of Biological Chemistry.

[7]  M. Devoto,et al.  Localization of a gene responsible for autosomal recessive demyelinating neuropathy with focally folded myelin sheaths to chromosome 11q23 by homozygosity mapping and haplotype sharing. , 1996, Human molecular genetics.

[8]  Michael E Shy,et al.  Hereditary motor and sensory neuropathies: a biological perspective , 2002, The Lancet Neurology.

[9]  Thomas Pk,et al.  Autosomal recessive hereditary motor and sensory neuropathy , 2000, Current opinion in neurology.

[10]  Davide Pareyson,et al.  Diagnosis, natural history, and management of Charcot–Marie–Tooth disease , 2009, The Lancet Neurology.

[11]  Michelangelo Foti,et al.  PIKfyve controls fluid phase endocytosis but not recycling/degradation of endocytosed receptors or sorting of procathepsin D by regulating multivesicular body morphogenesis. , 2003, Molecular biology of the cell.

[12]  Carsten Bergmann,et al.  Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. , 2003, Human molecular genetics.

[13]  K. Hayasaka,et al.  Periaxin mutation in Japanese patients with Charcot-Marie-Tooth disease , 2006, Journal of Human Genetics.

[14]  Aldo Quattrone,et al.  Genetic refinement and physical mapping of the CMT4B gene on chromosome 11q22 , 2000 .

[15]  M. Rebecchi,et al.  Pleckstrin homology domains: a common fold with diverse functions. , 1998, Annual review of biophysics and biomolecular structure.

[16]  P. Ghosh,et al.  Knee MRI showing thickened peripheral nerves in Charcot–Marie–Tooth disease , 2012, Acta Neurologica Belgica.

[17]  R. Ravazzolo,et al.  Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma. , 2003, American journal of human genetics.

[18]  J. Dixon,et al.  The Phosphoinositide-3-phosphatase MTMR2 Associates with MTMR13, a Membrane-associated Pseudophosphatase Also Mutated in Type 4B Charcot-Marie-Tooth Disease* , 2005, Journal of Biological Chemistry.

[19]  Karen Nuytemans,et al.  Whole Exome Sequencing , 2020, Definitions.

[20]  Murim Choi,et al.  Application of Whole Exome Sequencing to Identify Disease-Causing Variants in Inherited Human Diseases , 2012, Genomics & informatics.

[21]  P K Thomas,et al.  Autosomal recessive forms of hereditary motor and sensory neuropathy. , 1980, Journal of neurology, neurosurgery, and psychiatry.

[22]  Marius Sudol,et al.  The Hippo signal transduction network in skeletal and cardiac muscle , 2014, Science Signaling.

[23]  Jose A Morcuende,et al.  Long-term results of reconstruction for treatment of a flexible cavovarus foot in Charcot-Marie-Tooth disease. , 2008, The Journal of bone and joint surgery. American volume.

[24]  P K Thomas,et al.  Mutations in the 5' region of the myotubularin-related protein 2 (MTMR2) gene in autosomal recessive hereditary neuropathy with focally folded myelin. , 2001, Brain : a journal of neurology.

[25]  T. Bird,et al.  Charcot-Marie-Tooth Neuropathy Type 4 , 2016 .

[26]  R A Mann,et al.  The pathogenesis and surgical management of foot deformity in Charcot-Marie-Tooth disease. , 2000, Foot and ankle clinics.

[27]  P K Thomas,et al.  Autosomal recessive hereditary motor and sensory neuropathy , 2000, Current opinion in neurology.

[28]  K. Claeys,et al.  Charcot‐Marie‐Tooth Disease: A Clinico‐genetic Confrontation , 2008, Annals of human genetics.

[29]  A. Quattrone,et al.  A new SBF2 mutation in a family with recessive demyelinating Charcot-Marie-Tooth (CMT4B2) , 2004, Neurology.

[30]  O. Combarros,et al.  Prevalence of hereditary motor and sensory neuropathy in Cantabria , 1987, Acta neurologica Scandinavica.

[31]  Isobel Franks Genetics: Variants in SBF2 gene associated with survival in pancreatic adenocarcinoma , 2013, Nature Reviews Gastroenterology &Hepatology.

[32]  Nada Jabado,et al.  What can exome sequencing do for you? , 2011, Journal of Medical Genetics.

[33]  P. Shannon,et al.  Exome sequencing identifies the cause of a Mendelian disorder , 2009, Nature Genetics.

[34]  C. van Broeckhoven,et al.  Mutations in GDAP1 , 2002, Neurology.

[35]  H. Skre,et al.  Genetic and clinical aspects of Charcot‐Marie‐Tooth's disease , 1974, Clinical genetics.

[36]  Jia Chen,et al.  Breathing Easier , 1996, Environmental Health Perspectives.

[37]  P K Thomas,et al.  The clinical features of hereditary motor and sensory neuropathy types I and II. , 1980, Brain : a journal of neurology.

[38]  P. de Jonghe,et al.  Treatment for Charcot-Marie-Tooth disease. , 2008, The Cochrane database of systematic reviews.

[39]  S. Emr,et al.  Phosphoinositide signaling and the regulation of membrane trafficking in yeast. , 2000, Trends in biochemical sciences.